Binding affinity and capacity for the uremic toxin indoxyl sulfate

Area of Science:

• Nephrology
• Biochemistry
• Clinical Chemistry

Background:

• Protein binding significantly hinders the removal of uremic toxins during conventional dialysis.
• Accumulation of protein-bound uremic toxins negatively impacts the health of patients undergoing maintenance dialysis.
• Targeting protein binding is a potential strategy to enhance toxin elimination.

Purpose of the Study:

• To investigate methods for weakening the protein binding of uremic toxins, specifically indoxyl sulfate (IS).
• To assess the impact of altered plasma conditions on IS binding affinity and capacity.
• To evaluate the potential of these modifications for improving dialytic elimination of IS.

Main Methods:

• Utilized ultrafiltration and equilibrium dialysis experiments.
• Manipulated plasma conditions by increasing sodium chloride (NaCl) concentration, temperature, and dilution.
• Measured the dissociation constant (K(D)) and protein-bound fraction of IS in plasma from healthy and uremic individuals.

Main Results:

• Indoxyl sulfate (IS) exhibited one-site binding in normal plasma.
• Increased NaCl concentration led to a dose-dependent increase in K(D), indicating weakened binding.
• Plasma dilution and higher temperatures also decreased the protein-bound fraction of IS.
• In uremic plasma, increasing NaCl concentration from 0.15 M to 0.75 M reduced the protein-bound IS fraction from 89% to 81%.

Conclusions:

• Increasing ionic strength (NaCl concentration), temperature, and dilution effectively enhance the free fraction of IS.
• These modifications facilitate better removal of IS during dialysis.
• Clinical application during dialysis could lead to improved long-term outcomes for maintenance dialysis patients.